Skylands Capital, LLC

13F Holdings History for Cytosorbents Corp - Common Stock, par value $0.001 per share (CTSO)

Symbol: CTSO on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share
Latest Disclosed Ownership: 3M shares
Security Ownership: 4.8%

Shares, Excluding Options vs Price

Value, Excluding Options

Skylands Capital, LLC ownership in Cytosorbents Corp Common Stock, par value $0.001 per share (CTSO)

2025-04-17 - Skylands Capital, LLC has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 3M shares of Cytosorbents Corp Common Stock, par value $0.001 per share (CTSO). This represents 4.8% percent ownership of the company. In their previous filing dated 2025-01-07, Skylands Capital, LLC had reported owning 2.78M shares, indicating an increase of 7.95% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Skylands Capital, LLC	4.8%	-6%	$3M	3M	+221,080	+7.95%	$1.00	13G	3/31/2025	17 Apr 2025 14:22:59
Skylands Capital, LLC	5.1%		$2.78M	2.78M			$1.00	13G	12/31/2024	7 Jan 2025 13:26:16

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	0.27%	-0.06%	$1.99M	2.13M	-489,450	-18.7%	$0.93	Q3 2025
6/30/2025	0.49%	-0.07%	$3.35M	2.62M	-385,987	-12.9%	$1.28	Q2 2025
3/31/2025	0.43%	+0.03%	$3M	3M	+221,080		$1.00	Q1 2025
12/31/2024	0.35%	+0%	$2.53M	2.78M	+26,195	+0.95%	$0.91	Q4 2024
9/30/2024	0.56%	-0.02%	$4.13M	2.76M	-85,351	-3%	$1.50	Q3 2024
6/30/2024	0.28%	0%	$2M	2.84M	-34,774	-1.21%	$0.70	Q2 2024
3/31/2024	0.38%	-0.05%	$2.73M	2.88M	-378,661	-11.6%	$0.95	Q1 2024
12/31/2023	0.53%	+0.05%	$3.61M	3.25M	+309,543	+10.5%	$1.11	Q4 2023
9/30/2023	0.84%	+0.04%	$5.54M	2.94M	+151,200	+5.41%	$1.88	Q3 2023
6/30/2023	1.44%	+0.02%	$10M	2.79M	+38,500	+1.4%	$3.59	Q2 2023
3/31/2023	1.36%	+0.1%	$9.28M	2.75M	+212,879	+8.37%	$3.37	Q1 2023
12/31/2022	0.62%	+0.05%	$3.94M	2.54M	+195,057	+8.31%	$1.55	Q4 2022
9/30/2022	0.53%	+0%	$3.19M	2.35M	+22,037	+0.95%	$1.36	Q3 2022
6/30/2022	0.75%	+0.06%	$5.09M	2.32M	+197,045	+9.26%	$2.19	Q2 2022
3/31/2022	0.82%	+0.07%	$6.79M	2.13M	+181,578	+9.33%	$3.19	Q1 2022
12/31/2021	0.94%	+0.05%	$8.16M	1.95M	+108,833	+5.92%	$4.19	Q4 2021
9/30/2021	1.84%	+0.06%	$14.9M	1.84M	+65,541	+3.7%	$8.12	Q3 2021
6/30/2021	1.58%	+0.19%	$13.4M	1.77M	+194,800	+12.4%	$7.55	Q2 2021
3/31/2021	1.74%	+0.06%	$13.7M	1.58M	+49,800	+3.26%	$8.68	Q1 2021
12/31/2020	1.77%	+0.12%	$12.2M	1.53M	+105,700	+7.43%	$7.97	Q4 2020
9/30/2020	1.9%	+0.31%	$11.3M	1.42M	+228,900	+19.2%	$7.98	Q3 2020
6/30/2020	2.09%	+0.12%	$11.8M	1.19M	+66,500	+5.9%	$9.90	Q2 2020
3/31/2020	1.94%	+0.54%	$8.71M	1.13M	+310,431	+38%	$7.73	Q1 2020
12/31/2019	0.46%	+0.02%	$3.14M	816K	+41,619	+5.38%	$3.85	Q4 2019
9/30/2019	0.57%	+0.07%	$3.89M	774K	+93,650	+13.8%	$5.03	Q3 2019
6/30/2019	0.62%	+0.04%	$4.5M	681K	+44,550	+7%	$6.61	Q2 2019
3/31/2019	0.67%	+0.15%	$4.82M	636K	+140,200	+28.3%	$7.57	Q1 2019
12/31/2018	0.66%	+0.05%	$4.01M	496K	+37,800	+8.25%	$8.08	Q4 2018
9/30/2018	0.76%	-0.06%	$5.91M	458K	-38,500	-7.75%	$12.90	Q3 2018
6/30/2018	0.75%	-0.29%	$5.66M	497K	-190,400	-27.7%	$11.40	Q2 2018
3/31/2018	0.64%	-0.04%	$4.84M	687K	-38,658	-5.33%	$7.05	Q1 2018
12/31/2017	0.61%	+0.19%	$4.72M	726K	+225,558	+45.1%	$6.50	Q4 2017
9/30/2017	0.41%	-0.08%	$3.1M	500K	-94,200	-15.9%	$6.20	Q3 2017
6/30/2017	0.35%	+0.17%	$2.56M	594K	+277,650	+87.7%	$4.30	Q2 2017
3/31/2017	0.2%	+0.18%	$1.43M	317K	+293,600	+1277%	$4.50	Q1 2017
12/31/2016	0.02%		$125K	23K			$5.43	Q4 2016
9/30/2016	0.02%	-0.03%	$147K	23K	-25,350	-52.4%	$6.39	Q3 2016
6/30/2016	0.04%	0%	$220K	48.4K	-4,150	-7.9%	$4.55	Q2 2016
3/31/2016	0.03%		$206K	52.5K			$3.92	Q1 2016
12/31/2015	0.04%		$292K	52.5K			$5.56	Q4 2015
9/30/2015	0.04%	+0.04%	$331K	52.5K	+52,500	NEW	$6.30	Q3 2015

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.